The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Rituximab Injection Market Research Report 2024
Synopsis
Rituximab injection sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer.
Global Rituximab Injection market is projected to reach US$ 5851 million in 2029, increasing from US$ 1502 million in 2022, with the CAGR of 20.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Rituximab Injection market research.
Key manufacturers engaged in the Rituximab Injection industry include Pfizer, Amgen, Roche, Celltrion, Innovent Biologics, Intas Pharmaceuticals, Shanghai Henlius Biotech, Fosun-Pharmaceutical and Lexicare Pharma, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Rituximab Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Rituximab Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Rituximab Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer
Amgen
Roche
Celltrion
Innovent Biologics
Intas Pharmaceuticals
Shanghai Henlius Biotech
Fosun-Pharmaceutical
Lexicare Pharma
Healthiza Lifescience
Kavya Pharma
Cadila Pharmaceuticals
Dr Reddy’s Laboratories
Hetero Group
Probiomed
TRPharma
Zenotech Laboratories
Segment by Type
100 ml
500 ml
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Rituximab Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Rituximab injection sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer.
Global Rituximab Injection market is projected to reach US$ 5851 million in 2029, increasing from US$ 1502 million in 2022, with the CAGR of 20.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Rituximab Injection market research.
Key manufacturers engaged in the Rituximab Injection industry include Pfizer, Amgen, Roche, Celltrion, Innovent Biologics, Intas Pharmaceuticals, Shanghai Henlius Biotech, Fosun-Pharmaceutical and Lexicare Pharma, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Rituximab Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Rituximab Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Rituximab Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer
Amgen
Roche
Celltrion
Innovent Biologics
Intas Pharmaceuticals
Shanghai Henlius Biotech
Fosun-Pharmaceutical
Lexicare Pharma
Healthiza Lifescience
Kavya Pharma
Cadila Pharmaceuticals
Dr Reddy’s Laboratories
Hetero Group
Probiomed
TRPharma
Zenotech Laboratories
Segment by Type
100 ml
500 ml
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Rituximab Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Rituximab Injection Market Overview
1.1 Product Overview and Scope of Rituximab Injection
1.2 Rituximab Injection Segment by Type
1.2.1 Global Rituximab Injection Market Value Comparison by Type (2023-2029)
1.2.2 100 ml
1.2.3 500 ml
1.3 Rituximab Injection Segment by Application
1.3.1 Global Rituximab Injection Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Rituximab Injection Market Size Estimates and Forecasts
1.4.1 Global Rituximab Injection Revenue 2018-2029
1.4.2 Global Rituximab Injection Sales 2018-2029
1.4.3 Global Rituximab Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Rituximab Injection Market Competition by Manufacturers
2.1 Global Rituximab Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Rituximab Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Rituximab Injection Average Price by Manufacturers (2018-2023)
2.4 Global Rituximab Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Rituximab Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rituximab Injection, Product Type & Application
2.7 Rituximab Injection Market Competitive Situation and Trends
2.7.1 Rituximab Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rituximab Injection Players Market Share by Revenue
2.7.3 Global Rituximab Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rituximab Injection Retrospective Market Scenario by Region
3.1 Global Rituximab Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Rituximab Injection Global Rituximab Injection Sales by Region: 2018-2029
3.2.1 Global Rituximab Injection Sales by Region: 2018-2023
3.2.2 Global Rituximab Injection Sales by Region: 2024-2029
3.3 Global Rituximab Injection Global Rituximab Injection Revenue by Region: 2018-2029
3.3.1 Global Rituximab Injection Revenue by Region: 2018-2023
3.3.2 Global Rituximab Injection Revenue by Region: 2024-2029
3.4 North America Rituximab Injection Market Facts & Figures by Country
3.4.1 North America Rituximab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Rituximab Injection Sales by Country (2018-2029)
3.4.3 North America Rituximab Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rituximab Injection Market Facts & Figures by Country
3.5.1 Europe Rituximab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Rituximab Injection Sales by Country (2018-2029)
3.5.3 Europe Rituximab Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rituximab Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Rituximab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Rituximab Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Rituximab Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Rituximab Injection Market Facts & Figures by Country
3.7.1 Latin America Rituximab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Rituximab Injection Sales by Country (2018-2029)
3.7.3 Latin America Rituximab Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rituximab Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Rituximab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Rituximab Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Rituximab Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rituximab Injection Sales by Type (2018-2029)
4.1.1 Global Rituximab Injection Sales by Type (2018-2023)
4.1.2 Global Rituximab Injection Sales by Type (2024-2029)
4.1.3 Global Rituximab Injection Sales Market Share by Type (2018-2029)
4.2 Global Rituximab Injection Revenue by Type (2018-2029)
4.2.1 Global Rituximab Injection Revenue by Type (2018-2023)
4.2.2 Global Rituximab Injection Revenue by Type (2024-2029)
4.2.3 Global Rituximab Injection Revenue Market Share by Type (2018-2029)
4.3 Global Rituximab Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Rituximab Injection Sales by Application (2018-2029)
5.1.1 Global Rituximab Injection Sales by Application (2018-2023)
5.1.2 Global Rituximab Injection Sales by Application (2024-2029)
5.1.3 Global Rituximab Injection Sales Market Share by Application (2018-2029)
5.2 Global Rituximab Injection Revenue by Application (2018-2029)
5.2.1 Global Rituximab Injection Revenue by Application (2018-2023)
5.2.2 Global Rituximab Injection Revenue by Application (2024-2029)
5.2.3 Global Rituximab Injection Revenue Market Share by Application (2018-2029)
5.3 Global Rituximab Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Rituximab Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Corporation Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Amgen Rituximab Injection Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Roche Rituximab Injection Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Celltrion
6.4.1 Celltrion Corporation Information
6.4.2 Celltrion Description and Business Overview
6.4.3 Celltrion Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Celltrion Rituximab Injection Product Portfolio
6.4.5 Celltrion Recent Developments/Updates
6.5 Innovent Biologics
6.5.1 Innovent Biologics Corporation Information
6.5.2 Innovent Biologics Description and Business Overview
6.5.3 Innovent Biologics Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Innovent Biologics Rituximab Injection Product Portfolio
6.5.5 Innovent Biologics Recent Developments/Updates
6.6 Intas Pharmaceuticals
6.6.1 Intas Pharmaceuticals Corporation Information
6.6.2 Intas Pharmaceuticals Description and Business Overview
6.6.3 Intas Pharmaceuticals Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Intas Pharmaceuticals Rituximab Injection Product Portfolio
6.6.5 Intas Pharmaceuticals Recent Developments/Updates
6.7 Shanghai Henlius Biotech
6.6.1 Shanghai Henlius Biotech Corporation Information
6.6.2 Shanghai Henlius Biotech Description and Business Overview
6.6.3 Shanghai Henlius Biotech Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shanghai Henlius Biotech Rituximab Injection Product Portfolio
6.7.5 Shanghai Henlius Biotech Recent Developments/Updates
6.8 Fosun-Pharmaceutical
6.8.1 Fosun-Pharmaceutical Corporation Information
6.8.2 Fosun-Pharmaceutical Description and Business Overview
6.8.3 Fosun-Pharmaceutical Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Fosun-Pharmaceutical Rituximab Injection Product Portfolio
6.8.5 Fosun-Pharmaceutical Recent Developments/Updates
6.9 Lexicare Pharma
6.9.1 Lexicare Pharma Corporation Information
6.9.2 Lexicare Pharma Description and Business Overview
6.9.3 Lexicare Pharma Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Lexicare Pharma Rituximab Injection Product Portfolio
6.9.5 Lexicare Pharma Recent Developments/Updates
6.10 Healthiza Lifescience
6.10.1 Healthiza Lifescience Corporation Information
6.10.2 Healthiza Lifescience Description and Business Overview
6.10.3 Healthiza Lifescience Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Healthiza Lifescience Rituximab Injection Product Portfolio
6.10.5 Healthiza Lifescience Recent Developments/Updates
6.11 Kavya Pharma
6.11.1 Kavya Pharma Corporation Information
6.11.2 Kavya Pharma Rituximab Injection Description and Business Overview
6.11.3 Kavya Pharma Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Kavya Pharma Rituximab Injection Product Portfolio
6.11.5 Kavya Pharma Recent Developments/Updates
6.12 Cadila Pharmaceuticals
6.12.1 Cadila Pharmaceuticals Corporation Information
6.12.2 Cadila Pharmaceuticals Rituximab Injection Description and Business Overview
6.12.3 Cadila Pharmaceuticals Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Cadila Pharmaceuticals Rituximab Injection Product Portfolio
6.12.5 Cadila Pharmaceuticals Recent Developments/Updates
6.13 Dr Reddy’s Laboratories
6.13.1 Dr Reddy’s Laboratories Corporation Information
6.13.2 Dr Reddy’s Laboratories Rituximab Injection Description and Business Overview
6.13.3 Dr Reddy’s Laboratories Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Dr Reddy’s Laboratories Rituximab Injection Product Portfolio
6.13.5 Dr Reddy’s Laboratories Recent Developments/Updates
6.14 Hetero Group
6.14.1 Hetero Group Corporation Information
6.14.2 Hetero Group Rituximab Injection Description and Business Overview
6.14.3 Hetero Group Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Hetero Group Rituximab Injection Product Portfolio
6.14.5 Hetero Group Recent Developments/Updates
6.15 Probiomed
6.15.1 Probiomed Corporation Information
6.15.2 Probiomed Rituximab Injection Description and Business Overview
6.15.3 Probiomed Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Probiomed Rituximab Injection Product Portfolio
6.15.5 Probiomed Recent Developments/Updates
6.16 TRPharma
6.16.1 TRPharma Corporation Information
6.16.2 TRPharma Rituximab Injection Description and Business Overview
6.16.3 TRPharma Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
6.16.4 TRPharma Rituximab Injection Product Portfolio
6.16.5 TRPharma Recent Developments/Updates
6.17 Zenotech Laboratories
6.17.1 Zenotech Laboratories Corporation Information
6.17.2 Zenotech Laboratories Rituximab Injection Description and Business Overview
6.17.3 Zenotech Laboratories Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Zenotech Laboratories Rituximab Injection Product Portfolio
6.17.5 Zenotech Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rituximab Injection Industry Chain Analysis
7.2 Rituximab Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rituximab Injection Production Mode & Process
7.4 Rituximab Injection Sales and Marketing
7.4.1 Rituximab Injection Sales Channels
7.4.2 Rituximab Injection Distributors
7.5 Rituximab Injection Customers
8 Rituximab Injection Market Dynamics
8.1 Rituximab Injection Industry Trends
8.2 Rituximab Injection Market Drivers
8.3 Rituximab Injection Market Challenges
8.4 Rituximab Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
